Our results show that when scaled on TG levels, the association between genetically predicted ANGPTL4 and CAD risk was greater in magnitude than for that of LPL activation and CAD risk, suggesting that the effect of ANGPTL4 on CAD may only be partly independent of LPL activation. This evidence concerns the gene LPL and coronary artery disorder.